Pt #     Diagnostic    Age (Sex)   Weight (kg)   DNA Chimerism (CD3 and CD33 subpopulations) % of Matched CBU     GVHD    Length of Hospital Stay    Overall Survival Days post-transplant           +14 +21 +28 +56 +100 At death     +100 2014-06-19 1 B-LPD 41 (M) 81 CD3 100% 100% 100% 100% 90% 100% Grade III (S/GI/K) 94 Alive Died +360 N/A CD33 100% 100% 100% 100% 96% 100% 2 CML-BC 32 (M) 56 CD3 100% 100% 100% 100% 100%   Grade II (S/GI) 99 Alive N/A Alive +1521 CD33 100% 100% 100% 100% 100%   3 AML 30 (F) 88 CD3 100% 100% 100% N/A N/A 100% Grade I (S) 27 Died +28 Died +28 N/A CD33 100% 100% 100% N/A N/A 100% 4 B-ALL 57 (F) 72 CD3 100% 100% 100% 100% 100%   Grade II (S/GI) 57 Alive N/A Alive +1081 CD33 100% 100% 100% 100% 100%   5 B-SLL 45 (M) 76 CD3 94% 35.5% 0% N/A N/A   N/A         CD33 100% 75% 0% N/A N/A   58 Alive N/A Alive +975 6 ALL 37 (F) 48 CD3 100% 100% 100% 100% 100%   Grade I (S) 47 Alive N/A Alive +597 CD33 100% 100% 100% 100% 100%   7 CML-BC 53 (M) 143 CD3 100% 100% 100% 100% N/A   Grade II (S) 64 Alive N/A Alive +507 CD33 100% 100% 100% 100% N/A   Mean 42 81 - - - - - - - - 64 - - - Median 41 76 - - - - - - - - 58 - - -

S = Skin; GI = gastrointestinal; L = Liver; K = Kidney; N/A = Not applicable B-LPD = B-liphoproliferative disorder, CML-BC = chronic myelogeneous leukemia in blast crisis, AML = acute myelogenous leukemia, ALL = acute lymphoblastic leukemia, SLL = small cell lymphocytic lymphoma.

Table 2: Summary of Transplant Outcomes.